Mission Statement

Mucosis’s mission is to discover and develop mucosal vaccines for the prevention and treatment of infectious diseases. It is our goal to transform excellent research into novel high-value vaccines which serve patients in need of a more efficacious therapy and improved patient convenience.
Contact Contact

22.09.09 Mucosis receives key US patent covering its Mimopath™ technology
more >

28.01.09 Mucosis B.V. and PATH start development of pneumococcal vaccines
more >

15.12.08 Mucosis B.V. and TNO announce flu vaccine research and development partnership.
more >

10.12.07 News article in “Het Financieele Dagblad”.
more >

06.11.08 Mucosis B.V. appoints Dr. Govert Schouten as CEO. more >

10.09.07 Mucosis raises € 3 million in first financing round more >